Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes

Gut

Volumn 56, Issue 2, 2007, Pages 168-175

  Mahmood, A ^b   FitzGerald, A J ^b   Marchbank, T ^a   Ntatsaki, E ^b   Murray, D ^c   Ghosh, S ^b   Playford, R J ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Lonza Inc USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; LACTULOSE; PLACEBO; POLAPREZINC; RHAMNOSE;

ABSENCE OF SIDE EFFECTS; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM INJURY; DOSE RESPONSE; DRUG MECHANISM; EPITHELIUM CELL; FEMALE; HEALTH FOOD; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; SMALL INTESTINE; STOMACH INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARNOSINE; CELL DIVISION; CELL LINE; CELL MOVEMENT; DIETARY SUPPLEMENTS; DOGS; GASTROINTESTINAL TRACT; HEALTH FOOD; HT29 CELLS; HUMANS; INDOMETHACIN; INTESTINE, SMALL; MALE; MICE; MODELS, ANIMAL; MODELS, BIOLOGICAL; ORGANOMETALLIC COMPOUNDS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; WOUND HEALING; ZINC COMPOUNDS;

EID: 33846959507     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.099929     Document Type: Article

References (20)

1. Boldyrev AA. Protection of proteins from oxidative stress: a new illusion or a novel strategy? Ann N Y Acad Sci 2005;1057:193-205.
2. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
3. Playford RJ, Floyd DN, Macdonald CE, et al. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 1999;44:653-8.
4. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice which overexpress the human trefoil peptide, pS2, have an increased resistance to intestinal damage. Proc Natl Acad Sci 1996;93:2137- 42.
5. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
6. Playford RJ, Macdonald CE, Calnan DP, et al. Co-administration of the health food supplement, bovine colostrum reduces the non steroidal anti-inflammatory drug induced increase in intestinal permeability. Clin Sci 2001;100:627-33.
7. Bjarnason I. Intestinal permeability. Gut 1994;35:S18-22.
8. Hardy MR, Townsend RR, Lee YC. Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal Biochem 1988;170:54-62.
9. MacDonald TM, Morant, SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997;315:1333-7.
10. Naiti Y, Yoshikawa T, Yagi N, et al. Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury. Dig Dis Sci 2001;46:845-51.
11. Levi S, Shaw-Smith C. Non-steroidal anti inflammatory drugs; how do they damage the gut? Br J Rheumatol 1994;33:605-12.
12. Fujii Y, Matsura T, Kai M, et al. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells. Jpn J Pharmacol 2000;84:63-70.
13. Honda O, Yoshida N, Tanaka Y, et al. Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori. Can J Gastroenterol 2002;11:785-9.
14. Hiraishi H, Sasai T, Oinuma T, et al. Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro. Aliment Pharmacol Ther 1999;13:261-9.
15. Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA 2005;102:2916-21.
16. McCarthy D. Non-steroidal anti-inflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology 1989;96:662-74.
17. Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic non-steroidal anti-inflammatory drug use. Am J Gastroenterol 1987;82:1153-8.
18. Morris AJ, Wasson LA, MacKenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992;33:887-9.
19. Bjarnason I, Hayllar J, Macpherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47.
20. Sloan AE. The top 10 functional food trends. Next Generation Food Technol 2002;56:32-57.